Skip to main content

Cannae Holdings, Inc. (CNNE) Stock Forecast

Data as of May 9, 2026

Consumer Cyclical · Current price $14.27 (+2.00%)

Consensus Target
$16.00
Upside
+19.1%
Analysts
2
Rating
Buy(2.00)

Price Target Range

Low $16.00High $16.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

CNNE vs Sector & Market

MetricCNNEConsumer Cyclical AvgLarge Cap Avg
Analyst Rating2.002.532.41
Analyst Count21319
Target Upside+19.1%+399.3%+16.4%
P/E Ratio-1.2812.0627.60

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$101M$103M$104M1
2026-09-30$99M$101M$102M1
2026-12-31$101M$102M$104M1
2027-03-31$97M$99M$100M1
2027-06-30$96M$98M$99M1
2027-09-30$96M$97M$98M1
2027-12-31$95M$96M$98M1

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$-0.47$-0.46$-0.451
2026-09-30$-0.47$-0.46$-0.451
2026-12-31$-0.49$-0.48$-0.471
2027-03-31$-0.41$-0.40$-0.391
2027-06-30$-0.41$-0.40$-0.391
2027-09-30$-0.39$-0.38$-0.371
2027-12-31$-0.40$-0.39$-0.381

Frequently Asked Questions

What is the analyst consensus for CNNE?

The consensus among 2 analysts covering Cannae Holdings, Inc. (CNNE) is Buy with an average price target of $16.00.

What is the highest price target for CNNE?

The highest analyst price target for CNNE is $16.00.

What is the lowest price target for CNNE?

The lowest analyst price target for CNNE is $16.00.

How many analysts cover CNNE?

2 analysts have issued ratings for Cannae Holdings, Inc. in the past 12 months.

Is CNNE a buy or sell right now?

Based on 2 analyst ratings, CNNE has a consensus rating of Buy (2.00/5) with a +19.1% upside to the consensus target of $16.00.

What are the earnings estimates for CNNE?

Analysts estimate CNNE will report EPS of $-0.46 for the period ending 2026-06-30, with revenue estimated at $103M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.